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Introduction
Endothelial cells (ECs) play central roles in the development 
of vasculature essential for embryogenesis (Folkman, 1995; 
Dvorak, 2003). The survival and function of ECs are regulated 
by complex interactions among growth factor receptors, inte-
grin receptors, and their extracellular ligands, which can trigger 
multiple intracellular signaling pathways through cytoplasmic   
kinases, small GTPases, and other adaptor molecules. FAK 
is a major mediator of signal transduction by integrins and also 
participates in signal transduction by growth factor recep-
tors such as VEGF receptors in ECs (Schaller, 2001; Parsons, 
2003; Schlaepfer and Mitra, 2004; Cohen and Guan, 2005; 
Siesser and Hanks, 2006). A role of FAK in vascular de-
velopment has been established by recent findings that EC-
  specific deletion of FAK results in embryonic lethality caused 
by decreased survival and other defects of ECs (Shen et al., 
2005; Braren et al., 2006). However, little is known about the   
mechanisms  by  which  FAK  exerts  its  regulatory  functions 
through multiple target molecules and signaling pathways in 
embryonic development.
Recent studies suggest that FAK functions not only as   
a kinase but also through its kinase-independent activities in 
different cellular processes (Shen et al., 2005; Lim et al., 2008). 
Nevertheless, whether kinase activity of FAK is required for 
survival and/or function of ECs in vascular development and 
embryogenesis is not clear. In this study, we address this issue 
directly by creating a FAK knockin mouse model with kinase-
defective (KD) mutant allele in endogenous FAK gene in ECs. 
Analysis of the EC-specific FAK mutant knockin embryos and 
isolated ECs revealed both kinase-independent and -dependent 
functions of FAK in EC survival and their barrier function,   
respectively, which are required for vascular development and 
embryogenesis at different stages.
F
ocal adhesion kinase (FAK) is essential for vascular 
development as endothelial cell (EC)–specific knock-
out of FAK (conditional FAK knockout [CFKO] mice) 
leads to embryonic lethality. In this study, we report the 
differential kinase-independent and -dependent functions 
of FAK in vascular development by creating and ana-
lyzing an EC-specific FAK kinase-defective (KD) mutant 
knockin (conditional FAK knockin [CFKI]) mouse model. 
CFKI embryos showed apparently normal development 
through embryonic day (E) 13.5, whereas the majority 
of CFKO embryos died at the same stage. Expression of 
KD FAK reversed increased EC apoptosis observed with 
FAK deletion in embryos and in vitro through suppression 
of up-regulated p21. However, vessel dilation and defec-
tive angiogenesis of CFKO embryos were not rescued in 
CFKI embryos. ECs without FAK or expressing KD FAK 
showed increased permeability, abnormal distribution of 
vascular endothelial cadherin (VE-cadherin), and reduced   
VE-cadherin Y658 phosphorylation. Together, our data 
suggest that kinase-independent functions of FAK can sup-
port EC survival in vascular development through E13.5 
but are insufficient for maintaining EC function to allow 
for completion of embryogenesis.
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allele by Tie2-Cre) but contained functional FAK (i.e., the flox   
allele) in other cells, and therefore were designated as condi-
tional FAK knockin (CFKI) mice. Parallel crosses between 
FAK
flox/+;Tie2-Cre and FAK
flox/flox were also performed to generate   
FAK
flox/flox;Tie2-Cre mice (i.e., CFKO mice in which both FAK 
alleles were converted to the deleted allele, thus inactivating FAK 
completely in ECs; Shen et al., 2005) for comparison with CFKI 
mice. As shown in Table I, both CFKI and CFKO embryos were 
recovered at Mendelian ratios at E12.5. At E13.5, CFKI embryos 
were still at Mendelian ratio, and the majority of the embryos   
appeared normal in gross appearance (Fig. 1 A). In contrast, much 
fewer CFKO embryos than Mendelian ratio were recovered,   
and most showed various vascular defects, including multifocal   
superficial hemorrhages and edema, as described previously (Shen 
et al., 2005). At E14.5 and later, reduced CFKI embryos were 
found, and surviving embryos exhibited various vascular defects 
too, whereas no live CFKO embryos were present at these stages. 
Lastly, we did not detect any live pups for either CFKI or CFKO 
mice out of >200 examined.
Consistent with observation of gross morphology, histo-
logical examination also showed rescue of various vascular de-
fects in CFKI embryos. As shown in Fig. 1 B, perivascular 
hemorrhages were found in the CFKO embryos (b), whereas all 
red blood cells were restricted inside the intact vessels in the 
control embryos (a), as shown previously (Shen et al., 2005). 
Interestingly, this phenotype was not found in CFKI embryos 
(Fig. 1 B, c), suggesting that these vascular defects were res-
cued by the kinase-independent functions of FAK. The fetal 
placental tissues increase noticeably with significant vascular-
ization of the vital organ in midgestation (Watson and Cross, 
2005). As shown previously (Shen et al., 2005), defective vas-
cularization caused significant decrease in the thickness of the 
labyrinth layer of CFKO placenta compared with control pla-
centa (Fig. 1 C). Analysis of CFKI placenta showed restored 
thickness of their labyrinth layer, suggesting that the kinase- 
independent functions of FAK were able to support placenta 
vascularization through E13.5. Consistent with this, the lack of 
vessels containing nucleated red blood cells (i.e., fetal vessels; 
Fig. 1 B, d–f, arrows) in CFKO placenta was also rescued in 
CFKI placenta.
Results and discussion
Generation of KD FAK mutant knockin mice
To  study  the  potential  role  of  kinase-independent  functions 
of FAK in vivo, we generated a KD mutant FAK allele in the 
endogenous FAK gene using a gene knockin approach via ho-
mologous recombination. The K454 to R mutation abolishing 
FAK kinase activity was created in exon 16 of FAK genomic 
DNA, and a targeting vector containing the mutated exon 16 
and a neomycin cassette (KD[neo] allele) was used to gener-
ate mutant mice containing the knockin mutant allele (Fig. S1),   
as described in Materials and methods. All FAK
+/KD mice were 
viable, fertile, and indistinguishable from wild-type mice, con-
firming  that  one  functional  FAK  allele  is  sufficient  for  nor-
mal mouse development and that the KD mutant allele (in the 
endogenous gene and not overexpressed) did not exhibit any 
dominant-negative effect severe enough to result in embryonic 
lethality and/or sterility for the mice. Mating between heterozy-
gous FAK
+/KD mice yielded wild-type (i.e., FAK
+/+) and FAK
+/KD 
mice at the expected 1:2 Mendelian ratio, but no homozygous   
FAK knockin (i.e., FAK
KD/KD) mice were detected after >400 pups   
were screened (unpublished data). Analysis of embryos from 
intercrosses of FAK
+/KD mice did not detect any live FAK
KD/KD 
embryos beyond embryonic day (E) 10.5 (unpublished data). 
These results suggested that the kinase activity of FAK is re-
quired for embryogenesis and that the kinase-independent func-
tions of FAK are not sufficient to rescue the early embryonic 
lethality of FAK KO mice.
KD FAK is sufficient to rescue vascular 
developmental defects in conditional FAK 
knockout [CFKO] mice through E13.5
To investigate the potential role of kinase-independent functions 
of FAK in vascular development in vivo, we crossed FAK
+/KD  
mice to Tie2-Cre mice expressing Cre recombinase in ECs   
(Koni et al., 2001) to generate FAK
+/KD;Tie2-Cre mice, which 
were then crossed with FAK
flox/flox (Shen et al., 2005) mice to pro-
duce FAK
flox/KD;Tie2-Cre mice (Table I). The FAK
flox/KD;Tie2-Cre 
mice expressed only KD FAK protein in ECs from the knockin 
KD mutant allele (flox allele was converted to the deleted   
Table I.  Genotypes of progeny from crosses to generate CFKI and CFKO mice
Genotypes E12.5 E13.5 E14.5 E15.5 E16.5 Born
Progeny from crosses between 
FAK
+/KD;Tie2-Cre and  
FAK
flox/flox mice
flox/KD 7 36 25 24 10 79
flox/KD;Tie2-Cre (CFKI) 9 40 9 4 1 0
flox/+ 8 35 27 19 12 92
flox/+;Tie2-Cre 6 37 30 19 10 85
Progeny from crosses between 
FAK
+/flox;Tie2-Cre and  
FAK
flox/flox mice
flox/flox 12 33 13 ND ND 72
flox/flox;Tie2-Cre (CFKO) 12 15 0 ND ND 0
flox/+ 12 37 14 ND ND 71
flox/+;Tie2-Cre 16 40 16 ND ND 68957 Kinase-independent function of FAK in vascular development • Zhao et al.
Together,  these  results  suggest  that  kinase-independent 
functions  of  FAK  are  able  to  support  vascular  development 
through E13.5 by rescuing the deficiency caused by deletion of 
FAK in ECs. They also indicate that the kinase activity of FAK 
is required for late stages of vascular development to support 
the completion of embryogenesis.
Figure 1.  Kinase-independent functions of FAK are sufficient to support normal embryonic development through E13.5. (A) Gross examination of whole 
embryos at various stages with or without intact yolk sac. Note the significantly reduced vascular network in CFKO embryos at E13.5, which was restored 
in CFKI embryos (arrows). The edema (blue arrow) and hemorrhages (blue arrowhead) observed in CFKO at E13.5 are also absent in CFKI embryos. The 
CFKO embryos found at E14.5 and E15.5 were smaller and with marked abnormalities caused by embryonic death, whereas a significant fraction of 
CFKI embryos were alive with more limited defects. (B) H&E staining of skin and labyrinth layer of placenta sections of control, CFKO, and CFKI embryos 
at E13.5. In a–c, arrows mark red blood cells within vessels for control and CFKI embryos (a and c) and outside of vessels because of a hemorrhage in 
CFKO embryos (b). In d–f, note the reduced number of vessels that contain the nucleated red blood cells from fetal embryos (arrows) in CFKO mice (e) com-
pared with control and CFKI mice (d and f). Arrowheads mark maternal vessels containing enucleated red blood cells that are present in all three samples.   
(C) Placenta sections from control, CFKO, and CFKI embryos at E13.5 were stained with H&E. Mean ± SEM of calculated thickness of labyrinth layer from 
three independent experiments in multiple fields is shown as a percentage of the value in control embryos.
KD FAK promotes EC survival through 
regulation of p21
Because the reduced EC survival has been suggested as a major   
cause of vascular defects in CFKO mice (Shen et al., 2005; 
Braren et al., 2006), we examined whether KD FAK can res-
cue the increased EC apoptosis in CFKI embryos. As shown in   JCB • VOLUME 189 • NUMBER 6 • 2010   958
was able to rescue the defective survival of ECs caused by 
deletion of FAK in embryos.
To further define the role of kinase-independent func-
tions of FAK in EC-autonomous survival, ECs were isolated 
from FAK
flox/flox, FAK
flox/KD, and FAK
+/flox mice (Fig. S2, B and C)   
and infected by recombinant adenoviruses encoding Cre (Ad-Cre) 
to delete floxed FAK allele (Fig. S2 D), as described previ-
ously (Shen et al., 2005). As expected, Ad-Cre infection of 
FAK
flox/flox ECs but not ECs from FAK
+/flox mice led to their in-
creased apoptosis (Fig. 3, A and B). Interestingly, the presence 
Fig. 2 (A and B), increased apoptosis was found in the liver   
of CFKO embryos (b and e) compared with control embryos 
(a and d). Interestingly, the liver of CFKI embryos showed 
only a slight increase in apoptosis (c and f). The increased 
apoptosis in the placenta and skin of CFKO embryos was also 
rescued in CFKI embryos (Fig. 2, C–E). Double staining of 
brain sections revealed the presence of apoptotic ECs in the 
blood vessel of CFKO embryos but not CFKI or control em-
bryos (Fig. 2 F). Similar results were found in skin sections   
(Fig. S2 A and not depicted). These results suggest that KD FAK   
Figure 2.  Kinase-independent functions of FAK rescue the increased apoptosis induced by FAK deletion. (A–E) Sections from livers, skins, or placenta 
of control, CFKO, or CFKI embryos at E13.5 were analyzed by TUNEL assays. (A and C) Representative fields with arrows marking apoptotic cells.   
(B, D, and E) Mean ± SEM of relative number of apoptotic cells per field from three experiments. (F) Brain sections from control, CFKO, or CFKI embryos 
at E13.5 were analyzed by TUNEL assays followed by staining using PECAM-1 and Hoechst. ECs and blood cells (both green) are marked by arrowheads 
and asterisks, respectively. Apoptotic cells are marked by arrows (red). Note the presence of apoptotic ECs in the vessel of CFKO embryos but not control 
or CFKI embryos.959 Kinase-independent function of FAK in vascular development • Zhao et al.
Figure 3.  Kinase-independent functions of FAK suppress the increased apoptosis induced by FAK deletion in vitro. ECs from FAK
flox/flox, FAK
+/flox, and   
FAK
flox/KD mice were infected with Ad-Cre to delete the floxed FAK allele or Ad-lacZ as a control, as indicated. (A and B) The infected cells were then 
stained by Hoechst and analyzed for apoptosis using TUNEL assay. (A) Representative fields for ECs from FAK
flox/flox and FAK
flox/KD mice stained by Hoechst   
(a, d, g, and j) or TUNEL (b, e, h, and k) or merged images (c, f, i, and l). (B) Mean ± SEM from three experiments. (C) Aliquots of lysates from the infected 
cells were analyzed by Western blotting using various antibodies, as indicated. (D–F) The intensity of the pAkt (D), p21 (E), and p53 (F) bands was quanti-
fied from three independent experiments by densitometry. The mean ± SEM of relative intensity (normalized to lacZ-infected cells) is shown.JCB • VOLUME 189 • NUMBER 6 • 2010   960
of  KD  FAK  in Ad-Cre–infected  ECs  from  FAK
flox/KD  mice 
reversed  the  increased  apoptosis,  suggesting  that  kinase- 
independent functions of FAK are sufficient for EC survival, 
which may account for the rescued vascular development in 
CFKI embryos through E13.5.
To study possible mechanisms by which KD FAK res-
cued the increase of EC apoptosis in FAK-null ECs, lysates 
were prepared and analyzed for FAK downstream targets. As 
shown in Fig. 3 C, deletion of flox FAK by Ad-Cre abolished 
FAK expression in ECs from FAK
flox/flox mice (lanes 1 and 2)   
but  did  not  affect  FAK  expression  in  ECs  from  FAK
+/flox  
and FAK
flox/KD mice because of the remaining wild-type or KD   
allele (lanes 3–6). Similar FAK autophosphorylation at Y397 
was detected in ECs infected by Ad-lacZ and FAK
+/flox ECs   
infected by Ad-Cre (Fig. 3 C, lanes 1 and 3–5). As expected, 
KD FAK in FAK
flox/KD ECs infected by Ad-Cre was not auto-
phosphorylated at Y397 (Fig. 3 C, lane 6). No significant dif-
ference in the expression or activation of FAK-related kinase 
Pyk2 was observed in ECs with FAK deletion or expression of 
KD FAK. Akt has been implicated in mediating FAK regulation 
of cell survival in previous studies (Frisch et al., 1996; Chan   
et al., 1999; Sonoda et al., 2000). However, activation of Akt was 
not changed in ECs with FAK deletion or with only KD FAK 
compared with controls (Fig. 3, C and D). In contrast, we found 
that p21 was increased upon deletion of FAK, but infection of 
ECs from FAK
flox/KD or FAK
+/flox mice by Ad-Cre did not lead to 
an increase of p21 (Fig. 3, C and E). Analysis of the mRNAs 
from these ECs by quantitative RT-PCR showed an 2.5-fold 
up-regulation of p21 mRNA upon deletion of FAK, whereas no 
differences were found in ECs from FAK
+/flox or FAK
flox/KD mice 
infected by Ad-Cre (Fig. S2 E). Moreover, inhibition of FAK 
by FAK-related nonkinase (FRNK) also increased p21 expres-
sion in ECs (Fig. S2 F), suggesting that this is not a second-
ary consequence of FAK deletion. Given the role of increased 
p21 in apoptosis (Sekiguchi and Hunter, 1998; Fotedar et al., 
1999), these results suggest that the up-regulation of p21 may 
contribute to increased EC apoptosis upon FAK deletion and 
that the kinase-independent functions of FAK could rescue EC 
apoptosis and defective vascular development through control-
ling p21 expression.
Lim et al. (2008) recently showed that FAK could facili-
tate p53 turnover in the nucleus through its FERM domain in   
a kinase-independent manner. However, no difference in the ex-
pression of p53 was observed in ECs upon FAK deletion or 
expression of KD FAK (Fig. 3, C and F). Although we cannot 
exclude the possibility that the activity of p53 (rather than its 
expression level) could be altered to regulate p21 in ECs, our 
current data suggest potentially p53-independent mechanisms 
of p21 regulation by FAK in a kinase-independent manner.
Defective angiogenesis and dilated vessels 
in CFKI embryos
We next examined the vascular defects besides EC apoptosis, 
which are not rescued by KD FAK and thus could be responsi-
ble for the later lethality of CFKI embryos (although not crucial 
for embryogenesis through E13.5). Consistent with previous 
findings (Shen et al., 2005; Braren et al., 2006), fewer blood 
vessels were found in the brain from CFKO embryos compared 
with control embryos (Fig. 4, A and B). CFKI embryos also 
showed a decreased number of vessels, suggesting that kinase-
independent functions of FAK were not sufficient to rescue 
the angiogenesis defects upon FAK deletion. In addition to the   
reduced vessel numbers, we observed evident dilation of vessels 
in both CFKO and CFKI embryos compared with control em-
bryos (Fig. 4, A and C). The defective vessel dilations were also 
found in other organs such as the spinal cord and skins of CFKO 
and CFKI embryos (Fig. 4, D–F). Examination of the embryos 
by whole-mount staining of PECAM-1 showed the enlarged 
vessels in CFKO embryos as well as CFKI embryos, although 
to a lesser extent, compared with control embryos at E12.5   
(Fig. S3 A). Together, these results suggest that the deficiency 
in the blood vessels, as exhibited by their dilation and reduced   
angiogenesis, was not rescued by KD FAK and could be respon-
sible for the embryonic lethality of the CFKI embryos, which 
were associated with signs of leaky vasculature such as multi-
focal hemorrhages and edema at later developmental stages.
FAK kinase activity is required  
for maintaining EC integrity and  
vascular endothelial cadherin  
(VE-cadherin) phosphorylation
To explore the potential mechanisms of the abnormal vascu-
lar integrity in CFKO and CFKI embryos, we examined the 
possible regulation of EC permeability by FAK by measur-
ing transport of FITC-dextran through a confluent monolayer   
of isolated ECs grown on Transwell plates, as described previ-
ously (Moldobaeva and Wagner, 2002). As shown in Fig. 5 A, 
deletion of FAK in FAK
flox/flox ECs by Ad-Cre increased their 
permeability, whereas infection of FAK
+/flox ECs by Ad-Cre had 
no effect. ECs with KD FAK (Ad-Cre infection of FAK
flox/KD 
ECs) also showed increased permeability, indicating that kinase 
activity of FAK was required to maintain the integrity of ECs. 
These results suggest that FAK regulates EC permeability and 
that the abnormalities in EC barrier function may contribute to 
the compromised integrity of the blood vessels, which, although 
they did not affect embryonic development through E13.5, man-
ifested in the severe hemorrhages and edema in the later stage 
of embryogenesis, leading to the lethality of CFKI embryos.
VE-cadherin is a major mediator of cell–cell adhesion 
of ECs and is responsible for regulation of their permeability   
under a variety of conditions (Gavard and Gutkind, 2006;   
Dejana et al., 2008). To understand regulation of EC permeabil-
ity by FAK, the expression and distribution of VE-cadherin was 
examined in FAK
flox/flox and FAK
flox/KD ECs infected by Ad-lacZ 
or Ad-Cre (Fig. 3 C and Fig. S2 D). As shown in Fig. 5 B,   
ECs infected by Ad-lacZ showed smooth and continuous stain-
ing of VE-cadherin on the membrane (a and c). In contrast, 
upon deletion of FAK in FAK
flox/flox ECs by Ad-Cre infection, 
the VE-cadherin exhibited a considerably different pattern with 
discontinuous staining and a more zigzag pattern (Fig. 5 B, b). 
Similarly, a disrupted pattern of VE-cadherin on the plasma 
membrane was observed in FAK
flox/KD ECs after Ad-Cre infec-
tion (Fig. 5 B, d). In contrast, no apparent differences in dis-
tribution of either -catenin or p120-catenin were observed in   961 Kinase-independent function of FAK in vascular development • Zhao et al.
Tyrosine phosphorylation of VE-cadherin has been shown 
to regulate its functions in cell–cell adhesion and vascular per-
meability previously (Esser et al., 1998; Allingham et al., 2007;   
Turowski et al., 2008). Therefore, we examined phosphoryla-
tion of Y658 of VE-cadherin, which could increase EC perme-
ability by decreasing VE-cadherin association with p120-catenin   
these cells (Fig. S3 B). As the zigzag pattern of VE-cadherin 
distribution at cell–cell junctions has been correlated with in-
creased permeability of ECs (Lampugnani et al., 1995; Esser   
et al., 1998; Lampugnani et al., 2002), these results suggest 
that  FAK  may  affect  EC  integrity  through  its  regulation  of   
VE-cadherin in a kinase-dependent manner.
Figure 4.  KD FAK is unable to rescue the re-
duced angiogenesis and vessel dilation caused 
by FAK deletion. (A) Brain sections from con-
trol, CFKO, and CFKI embryos at E13.5 were 
stained with anti–PECAM-1. Note the reduced 
density and dilated vessels (arrows) in CFKO 
and CFKI embryos (b and c) compared with 
control embryos (a). (B) Mean ± SEM of ves-
sel numbers per field from three independent 
experiments.  (C)  Mean  ±  SEM  of  relative 
vessel size normalized to the value in control 
embryos from three independent experiments.   
(D)  Sections  from  spinal  cords  (a–c)  or  skin 
(d–f)  of  control,  CFKO,  and  CFKI  embryos 
at  E13.5  were  stained  with  anti–PECAM-1.   
Vessels are marked by arrows. (E and F) Mean ±   
SEM of relative vessel size normalized to the 
value in control embryos from three indepen-
dent experiments.JCB • VOLUME 189 • NUMBER 6 • 2010   962
Figure 5.  Normal EC barrier function and distribution and Y658 phosphorylation of VE-cadherin requires FAK kinase activity. ECs from FAK
flox/flox, FAK
+/flox,   
and FAK
flox/KD mice were infected with Ad-Cre (closed bars) to delete the floxed FAK allele or Ad-lacZ (open bars) as a control, as indicated. (A) The 
infected cells were analyzed for their barrier function using Transwell assay as described in Materials and methods. The mean ± SEM of relative EC 
permeability (normalized to lacZ-infected cells) is shown. (B) Representative images of immunofluorescent staining by anti–VE-cadherin for infected 
cells from FAK
flox/flox and FAK
flox/KD mice. Arrows mark the discontinuous pattern of VE-cadherin distribution in cells infected with Ad-Cre. (C) Aliquots 
of lysates from the infected cells were analyzed by Western blotting using various antibodies, as indicated. (D) The intensity of the VE-cadherin pY658 
bands was quantified from three independent experiments by densitometry. The mean ± SEM of relative intensity (normalized to lacZ-infected cells) is 
shown. (E) A working model of kinase-dependent (absent in both CFKI and CFKO embryos) and -independent (present in CFKI embryos) functions of 
FAK in vascular development.963 Kinase-independent function of FAK in vascular development • Zhao et al.
Materials and methods
Construction of the targeting vector and generation of CFKI mice
Based on available mouse genome sequences in the Ensembl database, 
an isogenic 129SvJ mouse BAC genomic clone containing FAK exon 16 
(where the key K454 residue is encoded) and flanking sequences were 
obtained from BACPAC Resources Center. The presence of exon 16 in the 
BAC clone was verified by PCR using two pairs of primers surrounding 
exon 16 as well as Southern blotting. A targeting vector containing a mu-
tated exon 16 (K454 to R) and a neomycin cassette was then constructed 
for homologous recombination (Fig. S1 A).
Gene targeting in 129P2/OlaHsd-derived E14Tg2a mouse embry-
onic stem cells (Skarnes, 2000) was performed as described previously 
(Kendall et al., 1995) with the use of ESGRO (Millipore). Chimeric mice 
were identified by coat color and then bred to C57BL/6J mice. Trans-
mission of the germ line was identified by PCR (see next section) and 
confirmed by Southern blotting. Heterozygous targeted mice bearing the 
KD[neo] allele (FAK
+/KD[neo] mice) were obtained and then crossed with 
EIIa-Cre mice (The Jackson Laboratory), which express Cre in the very 
early stage of embryogenesis (Lakso et al., 1996), to delete the neomycin 
cassette to avoid its possible interference with FAK gene expression. The 
progenies with neomycin cassette removed (FAK
+/KD;EIIa-Cre mice) were 
crossed with C57BL/6J mice to segregate the FAK KD allele from the 
heterozygote EIIa-Cre transgene. The resulting heterozygous FAK knockin 
mice (FAK
+/KD mice) were identified by PCR analysis and confirmed by 
sequencing of tail DNA.
Tie2-Cre transgenic mice and CFKO mice have been described pre-
viously (Koni et al., 2001; Shen et al., 2005). All mice used in this study 
were bred and maintained at the University of Michigan under specific 
pathogen-free conditions in accordance with institutional guidelines.
Genotyping by PCR
Mice and embryos were genotyped by PCR analysis of genomic DNA. 
Isolation of genomic DNA was described previously (Chiang et al., 2000). 
Primers  used  to  genotype  flox  and    FAK  alleles  were  5-GCTGAT-
GTCCCAAGCTATTCC-3 and 5-AGGGCTGGTCTGCGCTGACAGG-3, 
as described previously (Shen et al., 2005). Primers used to genotype the   
FAK KD knockin allele were P1 5-TCAACAGCATGTAACTTCCC-3 and 
P2 5-GGCATTCCAGTGCAAAACAC-3 shown in Fig. S1 A. PCR was   
performed for 30 cycles of 94°C for 3 min, 67°C (for flox allele) or 60°C (for   
KD allele) for 2 min, and 72°C for 4 min. CreF (5-GCAGAACCTGAAGATGTT-
CGCGATTA-3) and CreR (5-TCTCCCACCGTCAGTACGTGAGATATC-3)   
primers were used to detect the Cre transgene, which was performed for   
35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s.
Morphological, histological, and immunohistochemical analysis
Timed matings were set up between male FAK
+/KD;Tie2-Cre and female 
FAK
flox/flox mice to generate CKFI and control mice or male FAK
+/flox;Tie2-Cre 
and female FAK
flox/flox mice to generate CFKO and control mice, respec-
tively. Embryos, yolk sacs, and placenta were harvested between E12.5 
and E15.5, fixed in 4% PFA in PBS at 4°C for 4–16 h, and transferred 
to 70% ethanol. They were examined for gross morphology and photo-
graphed on a dissecting microscope (model S6D; Leica) with a progres-
sive 3CCD camera (Sony) and Image-Pro Plus version 3.0.00.00 (Media 
Cybernetics) at RT. The embryos and placenta were embedded in paraffin, 
sectioned (5 µm), and stained with hematoxylin and eosin (H&E) or nuclear 
dye Hoechst 33258 (Sigma-Aldrich) or used for immunohistochemistry. The 
slides were examined under a microscope (model BX41; Olympus) with 
UplanF1 10× NA 0.3 or UplanF1 20× NA 0.5 objective lenses at RT, 
and the images were captured using a camera (model DP70; Olympus) 
with DP Controller version 1.2.1.108 (Olympus). For immunohistochemical 
analysis, the slides were subjected to staining using primary antibodies 
against PECAM-1, VE-cadherin, -catenin (all from Santa Cruz Biotech-
nology, Inc.) followed by biotinylated and peroxidase-conjugated second-
ary antibodies. They were then processed using the DAB immunostaining   
assay kit (Santa Cruz Biotechnology, Inc.) according to the instructions.   
The samples were usually counterstained with hematoxylin before mount-
ing on coverslips.
For the whole-mount staining with anti–PECAM-1 antibody, embryos   
were fixed in 4% PFA/PBS. After dehydration by a series of methanol, 
they were treated with 1% H2O2 (diluted in MeOH and DMSO mixed 
4:1) to quench endogenous peroxidases. Samples were rehydrated by 
methanol to PBS and blocked in 4% BSA with 0.1% Triton X-100 in PBS. 
They were then incubated with anti–PECAM-1 (rat monoclonal MEC13.3; 
1:50 dilution; BD) diluted 1:10 in 4% BSA in PBS + 0.05% Tween at 4°C 
(Potter et al., 2005). To our surprise, infection of FAK
flox/flox or 
FAK
flox/KD ECs but not FAK
+/flox ECs by Ad-Cre reduced Y658 
phosphorylation rather than increased it (Fig. 5, C and D). Y658 
is a site of phosphorylation by Src upon VEGF stimulation 
(Potter et al., 2005), which is also dependent on Pyk2 in the 
phosphorylation induced by leukocyte binding through ICAM1 
(Allingham et al., 2007). Our results suggest that the basal phos-
phorylation of this residue also requires FAK kinase activity. 
Interestingly, similar activation levels of Src were found in ECs 
without FAK or KD FAK only, compared with control cells 
(Fig. 5 C), suggesting that FAK may promote Src phosphory-
lation of Y658 through a scaffolding function, which requires 
autophosphorylation of Y397 (Fig. 3 C), rather than by increas-
ing Src activity by itself. Interestingly, a recent study showed 
that deletion of exon 15 (containing Y397) of FAK also caused 
late embryonic lethality with multiple vascular defects similar 
to those in CFKI embryos (Corsi et al., 2009), suggesting that 
defective basal Y658 phosphorylation in VE-cadherin mediated 
by FAK could also be responsible in these embryos.
Conclusions
By creating a KD FAK knockin allele in mice, we identified both 
kinase-independent and -dependent functions of FAK important 
in vascular development, as shown in a working model (Fig. 5 E). 
Deletion of FAK in ECs results in their increased apoptosis and 
more subtle defects like increased permeability, leading to embry-
onic lethality around E13.5. The expression of KD FAK was able 
to rescue the increased EC apoptosis through regulation of p21   
by kinase-independent functions of FAK to allow further develop-
ment of the embryos beyond this stage. However, FAK kinase   
activity is required for maintaining normal barrier function of   
ECs through proper phosphorylation of Y658 of VE-cadherin.   
As CFKI embryos progressed in development, these subtle vascu-
lar defects led to lethality around E15.5, possibly as a result of the 
increased reliance of embryos on vessel integrity as they got big-
ger, the increased severity of defects in vessel integrity, or both.
Tyrosine kinases play essential roles in many biological 
processes, including vascular development, and identification of 
their targets has been the focus of studies over the years (for 
reviews see Hunter, 2009; Pawson and Kofler, 2009). Our results 
demonstrating a kinase-independent function of FAK in vascu-
lar development raise the possibility of such mode of actions by 
other tyrosine kinases in development and diseases. Therefore, 
future investigation on such possibilities (especially in the con-
text of in vivo developmental or disease models) will comple-
ment the efforts in identifying key substrates of tyrosine kinases 
to provide a better understanding of tyrosine kinase signaling 
mechanisms. Future studies will also be necessary to clarify the 
specific FAK kinase–independent and –dependent downstream 
pathways in the regulation of crucial targets involved in ECs and 
perhaps other cell types in embryogenesis and other biological 
processes. The direct demonstration of both kinase-independent 
and -dependent functions of FAK in vivo highlights the necessity 
to develop drugs that can inhibit all of FAK functions beyond 
the currently available kinase inhibitors for FAK (Halder et al., 
2007; Slack-Davis et al., 2007; Roberts et al., 2008) in the treat-
ment of cancer and possibly other diseases.JCB • VOLUME 189 • NUMBER 6 • 2010   964
with Hoechst. Samples were embedded with antifade and subjected to   
observation under a BX41 microscope with a UplanF1 20× NA 0.5 objec-
tive lens at RT. The images were captured using a DP70 camera with   
DP Controller version 1.2.1.108.
Transwell permeability assay
Permeability across the EC monolayer was measured by using type I   
collagen–coated  Transwell  units  (6.5-mm  diameter  and  3.0-µm  pore   
size polycarbonate filter; Corning), essentially as described previously 
(Moldobaeva and Wagner, 2002). In brief, ECs infected with adenovirus 
were plated at 10
5 cells in each well and cultured for 2 d to get confluent 
before experiments. After cells were serum starved in medium 199 contain-
ing 1% BSA for 1 h, permeability was measured by adding 1 mg of FITC-
labeled dextran (molecular weight, 42,000)/ml to the upper chamber. 
After incubation for 30 min, 50 µl of sample from the lower compartment 
was diluted with 300 µl PBS and measured for fluorescence at 520 nm 
when excited at 492 nm with a spectrophotometer (Synergy HT; BioTek).
Immunofluorescence staining
ECs infected with Ad-lacZ or Ad-Cre were processed for immunofluores-
cence staining using anti–VE-cadherin (BD) or -catenin or p120-catenin 
(both from Santa Cruz Biotechnology, Inc.), as described previously (Shen 
et al., 2005). Texas red–conjugated mouse anti–rat IgG (1:200), FITC-
conjugated goat anti–rabbit IgG (1:200), and FITC-conjugated goat anti–
mouse IgG (1:200) were used as the secondary antibodies. They were 
then mounted on Slowfade (Invitrogen) and examined under a BX41 micro-
scope with a UplanF1 20× NA 0.5 objective lens at RT. The images were 
captured using a DP70 camera with DP Controller version 1.2.1.108. For 
detection of EC apoptosis in vivo, brain sections were subjected to TUNEL 
assay as described above, followed by immunofluorescent staining using 
anti–PECAM-1 and Hoechst. Images of stained sections were captured   
using a laser-scanning confocal microscope (FluoView 500; Olympus) and 
a CCD camera at RT.
Online supplemental material
Fig. S1 shows generation of the KD FAK knockin allele. Fig. S2 shows 
analysis of embryonic liver sections in vivo and preparation and analy-
sis of primary ECs in vitro. Fig. S3 shows whole-mount analysis of em-
bryos  and  immunofluorescent  staining  of  isolated  primary  ECs.  Online 
supplemental  material  is  available  at  http://www.jcb.org/cgi/content/ 
full/jcb.200912094/DC1.
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